Trinity Biotech (TRIB) Accounts Payables (2016 - 2025)
Trinity Biotech's Accounts Payables history spans 17 years, with the latest figure at $29.7 million for Q4 2025.
- On a quarterly basis, Accounts Payables rose 10.91% to $29.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.7 million, a 10.91% increase, with the full-year FY2025 number at $29.7 million, up 10.91% from a year prior.
- Accounts Payables hit $29.7 million in Q4 2025 for Trinity Biotech, up from $26.5 million in the prior quarter.
- Over the last five years, Accounts Payables for TRIB hit a ceiling of $30.9 million in Q1 2021 and a floor of $12.2 million in Q3 2023.
- Historically, Accounts Payables has averaged $19.3 million across 5 years, with a median of $17.0 million in 2021.
- Biggest five-year swings in Accounts Payables: plummeted 49.36% in 2022 and later surged 109.2% in 2024.
- Tracing TRIB's Accounts Payables over 5 years: stood at $15.1 million in 2021, then increased by 1.64% to $15.4 million in 2022, then decreased by 16.73% to $12.8 million in 2023, then surged by 109.2% to $26.8 million in 2024, then increased by 10.91% to $29.7 million in 2025.
- Business Quant data shows Accounts Payables for TRIB at $29.7 million in Q4 2025, $26.5 million in Q2 2025, and $26.8 million in Q4 2024.